Cargando…

Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis

Numerous repositioned drugs have been sought to decrease the severity of SARS-CoV-2 infection. It is known that among its physicochemical properties, Ursodeoxycholic Acid (UDCA) has a reduction in surface tension and cholesterol solubilization, it has also been used to treat cholesterol gallstones a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodal Canales, Francisco Javier, Pérez-Campos Mayoral, Laura, Hernández-Huerta, María Teresa, Sánchez Navarro, Luis Manuel, Matias-Cervantes, Carlos Alberto, Martínez Cruz, Margarito, Cruz Parada, Eli, Zenteno, Edgar, Ramos-Martínez, Edgar Gustavo, Pérez-Campos Mayoral, Eduardo, Romero Díaz, Carlos, Pérez-Campos, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593036/
https://www.ncbi.nlm.nih.gov/pubmed/34782703
http://dx.doi.org/10.1038/s41598-021-01705-5
_version_ 1784599623476707328
author Rodal Canales, Francisco Javier
Pérez-Campos Mayoral, Laura
Hernández-Huerta, María Teresa
Sánchez Navarro, Luis Manuel
Matias-Cervantes, Carlos Alberto
Martínez Cruz, Margarito
Cruz Parada, Eli
Zenteno, Edgar
Ramos-Martínez, Edgar Gustavo
Pérez-Campos Mayoral, Eduardo
Romero Díaz, Carlos
Pérez-Campos, Eduardo
author_facet Rodal Canales, Francisco Javier
Pérez-Campos Mayoral, Laura
Hernández-Huerta, María Teresa
Sánchez Navarro, Luis Manuel
Matias-Cervantes, Carlos Alberto
Martínez Cruz, Margarito
Cruz Parada, Eli
Zenteno, Edgar
Ramos-Martínez, Edgar Gustavo
Pérez-Campos Mayoral, Eduardo
Romero Díaz, Carlos
Pérez-Campos, Eduardo
author_sort Rodal Canales, Francisco Javier
collection PubMed
description Numerous repositioned drugs have been sought to decrease the severity of SARS-CoV-2 infection. It is known that among its physicochemical properties, Ursodeoxycholic Acid (UDCA) has a reduction in surface tension and cholesterol solubilization, it has also been used to treat cholesterol gallstones and viral hepatitis. In this study, molecular docking was performed with the SARS-CoV-2 Spike protein and UDCA. In order to confirm this interaction, we used Molecular Dynamics (MD) in “SARS-CoV-2 Spike protein-UDCA”. Using another system, we also simulated MD with six UDCA residues around the Spike protein at random, naming this “SARS-CoV-2 Spike protein-6UDCA”. Finally, we evaluated the possible interaction between UDCA and different types of membranes, considering the possible membrane conformation of SARS-CoV-2, this was named “SARS-CoV-2 membrane-UDCA”. In the “SARS-CoV-2 Spike protein-UDCA”, we found that UDCA exhibits affinity towards the central region of the Spike protein structure of − 386.35 kcal/mol, in a region with 3 alpha helices, which comprises residues from K986 to C1032 of each monomer. MD confirmed that UDCA remains attached and occasionally forms hydrogen bonds with residues R995 and T998. In the presence of UDCA, we observed that the distances between residues atoms OG1 and CG2 of T998 in the monomers A, B, and C in the prefusion state do not change and remain at 5.93 ± 0.62 and 7.78 ± 0.51 Å, respectively, compared to the post-fusion state. Next, in “SARS-CoV-2 Spike protein-6UDCA”, the three UDCA showed affinity towards different regions of the Spike protein, but only one of them remained bound to the region between the region's heptad repeat 1 and heptad repeat 2 (HR1 and HR2) for 375 ps of the trajectory. The RMSD of monomer C was the smallest of the three monomers with a value of 2.89 ± 0.32, likewise, the smallest RMSF was also of the monomer C (2.25 ± 056). In addition, in the simulation of “SARS-CoV-2 membrane-UDCA”, UDCA had a higher affinity toward the virion-like membrane; where three of the four residues remained attached once they were close (5 Å, to the centre of mass) to the membrane by 30 ns. However, only one of them remained attached to the plasma-like membrane and this was in a cluster of cholesterol molecules. We have shown that UDCA interacts in two distinct regions of Spike protein sequences. In addition, UDCA tends to stay bound to the membrane, which could potentially reduce the internalization of SARS-CoV-2 in the host cell.
format Online
Article
Text
id pubmed-8593036
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85930362021-11-16 Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis Rodal Canales, Francisco Javier Pérez-Campos Mayoral, Laura Hernández-Huerta, María Teresa Sánchez Navarro, Luis Manuel Matias-Cervantes, Carlos Alberto Martínez Cruz, Margarito Cruz Parada, Eli Zenteno, Edgar Ramos-Martínez, Edgar Gustavo Pérez-Campos Mayoral, Eduardo Romero Díaz, Carlos Pérez-Campos, Eduardo Sci Rep Article Numerous repositioned drugs have been sought to decrease the severity of SARS-CoV-2 infection. It is known that among its physicochemical properties, Ursodeoxycholic Acid (UDCA) has a reduction in surface tension and cholesterol solubilization, it has also been used to treat cholesterol gallstones and viral hepatitis. In this study, molecular docking was performed with the SARS-CoV-2 Spike protein and UDCA. In order to confirm this interaction, we used Molecular Dynamics (MD) in “SARS-CoV-2 Spike protein-UDCA”. Using another system, we also simulated MD with six UDCA residues around the Spike protein at random, naming this “SARS-CoV-2 Spike protein-6UDCA”. Finally, we evaluated the possible interaction between UDCA and different types of membranes, considering the possible membrane conformation of SARS-CoV-2, this was named “SARS-CoV-2 membrane-UDCA”. In the “SARS-CoV-2 Spike protein-UDCA”, we found that UDCA exhibits affinity towards the central region of the Spike protein structure of − 386.35 kcal/mol, in a region with 3 alpha helices, which comprises residues from K986 to C1032 of each monomer. MD confirmed that UDCA remains attached and occasionally forms hydrogen bonds with residues R995 and T998. In the presence of UDCA, we observed that the distances between residues atoms OG1 and CG2 of T998 in the monomers A, B, and C in the prefusion state do not change and remain at 5.93 ± 0.62 and 7.78 ± 0.51 Å, respectively, compared to the post-fusion state. Next, in “SARS-CoV-2 Spike protein-6UDCA”, the three UDCA showed affinity towards different regions of the Spike protein, but only one of them remained bound to the region between the region's heptad repeat 1 and heptad repeat 2 (HR1 and HR2) for 375 ps of the trajectory. The RMSD of monomer C was the smallest of the three monomers with a value of 2.89 ± 0.32, likewise, the smallest RMSF was also of the monomer C (2.25 ± 056). In addition, in the simulation of “SARS-CoV-2 membrane-UDCA”, UDCA had a higher affinity toward the virion-like membrane; where three of the four residues remained attached once they were close (5 Å, to the centre of mass) to the membrane by 30 ns. However, only one of them remained attached to the plasma-like membrane and this was in a cluster of cholesterol molecules. We have shown that UDCA interacts in two distinct regions of Spike protein sequences. In addition, UDCA tends to stay bound to the membrane, which could potentially reduce the internalization of SARS-CoV-2 in the host cell. Nature Publishing Group UK 2021-11-15 /pmc/articles/PMC8593036/ /pubmed/34782703 http://dx.doi.org/10.1038/s41598-021-01705-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Rodal Canales, Francisco Javier
Pérez-Campos Mayoral, Laura
Hernández-Huerta, María Teresa
Sánchez Navarro, Luis Manuel
Matias-Cervantes, Carlos Alberto
Martínez Cruz, Margarito
Cruz Parada, Eli
Zenteno, Edgar
Ramos-Martínez, Edgar Gustavo
Pérez-Campos Mayoral, Eduardo
Romero Díaz, Carlos
Pérez-Campos, Eduardo
Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis
title Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis
title_full Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis
title_fullStr Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis
title_full_unstemmed Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis
title_short Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis
title_sort interaction of spike protein and lipid membrane of sars-cov-2 with ursodeoxycholic acid, an in-silico analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593036/
https://www.ncbi.nlm.nih.gov/pubmed/34782703
http://dx.doi.org/10.1038/s41598-021-01705-5
work_keys_str_mv AT rodalcanalesfranciscojavier interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT perezcamposmayorallaura interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT hernandezhuertamariateresa interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT sancheznavarroluismanuel interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT matiascervantescarlosalberto interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT martinezcruzmargarito interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT cruzparadaeli interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT zentenoedgar interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT ramosmartinezedgargustavo interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT perezcamposmayoraleduardo interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT romerodiazcarlos interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis
AT perezcamposeduardo interactionofspikeproteinandlipidmembraneofsarscov2withursodeoxycholicacidaninsilicoanalysis